Active Stocks

Thu Nov 21 2024 15:58:46

Tata Steel share price
140.25 0.57%

Tata Motors share price
773.70 -1.24%

State Bank Of India share price
780.85 -2.64%

NTPC share price
356.10 -2.73%

Power Grid Corporation Of India share price
325.80 3.41%

Business News/Topic/ Pharma Industry

PHARMA INDUSTRY

Get the latest Pharma industry news, videos and headlines. Explore more for Pharma industry breaking news, opinions, special reports and more on mint.

Home remedy: Indian pharma bets on domestic brands to fight US generics slowdown

4 min read . 08 Nov 2024

The NDPS Act regulates operations such as manufacture, transport, and consumption related to narcotic drugs and psychotropic substances. (Bloomberg)

Pharma department seeks report on drug misuse, eyes NDPS Act inclusion

3 min read . 14 Jun 2024

Here’s How Medicare Should Negotiate Drug Prices

Here’s How Medicare Should Negotiate Drug Prices

3 min read . 17 Apr 2024

Tata Institute has come with drugs to stop cancer recurrence

Tata Institute comes up with a ₹100 drug to prevent cancer recurrence

1 min read . 28 Feb 2024

The Federal Trade Commission building in Washington.

Drug Shortages Trigger FTC Probe

2 min read . 15 Feb 2024

Sumeet Bagadia of Choice Broking has chosen Cipla as his ‘Valentine's Day 2024 Pick’. Bagadia has recommended a ‘Buy’ on the pharma stock at ₹1,450 and up to ₹1,415 for a target price of ₹1,600 to ₹1,660. (REUTERS)

Sumeet Bagadia lists Cipla as top 'Valentine's Day 2024 Pick'; here's why

4 min read . 14 Feb 2024

President Biden speaking about prescription drug costs at the National Institutes of Health in Bethesda, Md., last month.

Trump and Biden Both Hate Pharma—Investors Shouldn’t

3 min read . 19 Jan 2024

The Nifty Healthcare index has shown remarkable growth over time, especially in the last decade. (Photo via Pixabay)

Your Questions Answered: Can you list pros and cons of investing in healthcare?

6 min read . 19 Jan 2024

When Braxton Clark was 18, he had a psychotic episode after using cannabis and was admitted to a hospital.

More Teens Who Use Marijuana Are Suffering From Psychosis

5 min read . 11 Jan 2024

Rising demand for the obesity drug Ozempic is expected to continue boosting its maker, Novo Nordisk, next year.

A Tale of Two Pharmas: Can Obesity Firms Continue Their Outperformance in 2024?

4 min read . 27 Dec 2023

Shares of Dr Reddy's Laboratories (DRL) shed almost 7 percent in trade on Monday after the US Food and Drug Administration (USFDA) issued three observations for the company's Telangana plant.

Dr Reddy's Laboratories sheds around 7% as USFDA issues 3 observations for firm

2 min read . 11 Dec 2023

USFDA issues warning letter to Intas Pharma

US FDA issues warning letter to Intas Pharma for manufacturing lapses

2 min read . 10 Dec 2023

Tylenol is manufactured by a consumer-health company spun off from Johnson & Johnson.

Lawsuits Seek to Link Tylenol Ingredient to Autism, ADHD

4 min read . 06 Dec 2023

Purdue Pharma headquarters in 2019; a Purdue lawyer said in court Monday that if a settlement with the company didn’t go forward, opioid-crisis victims might not see compensation.

Supreme Court Weighs Purdue Pharma’s $6 Billion Opioid Settlement

3 min read . 05 Dec 2023

Ozempic and similar drugs have surged in popularity in the U.S., sparking concern among some investors that broader adoption could threaten food companies’ sales in years to come.

Ozempic and a Protein Shake: Food Makers Prep Weight-Loss-Drug Side Dishes

5 min read . 04 Dec 2023

A Johnson & Johnson drug-discovery laboratory in Spring House, Pa., uses automation to screen millions to trillions of compounds, generating data that can later be analyzed by artificial intelligence to find molecules with potential to treat disease.

J&J Hired Thousands of Data Scientists. Will The Strategy Pay Off?

5 min read . 01 Dec 2023

Daniel Skovronsky, chief scientific and medical officer at Eli Lilly, pushed the company to move more quickly and focus more on science.

Can a Big Pharma Ever Be Worth $1 Trillion?

4 min read . 29 Nov 2023

Ebitda for the quarter stood at ₹315 crore and the Ebitda margin at 16%

Piramal Pharma revenue up 11% to ₹1,911 crore in Q2

1 min read . 28 Oct 2023

Novo Nordisk’s Ozempic Drug Shows Success in Kidney Trial, Boosting Shares

Novo Nordisk’s Ozempic Drug Shows Success in Kidney Trial, Boosting Shares

1 min read . 11 Oct 2023

Nuvama Institutional Equities: The brokerage firm anticipates domestic growth of 8% year over year (YoY), with Torrent Pharmaceuticals Ltd. and Cipla Ltd taking the top spots.

Q1 results preview: Here's why pharma companies are expected to show improvement

4 min read . 11 Jul 2023